• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Tessy Plastics Names Stafford Frearson as President

    HoneyNaps' AI Sleep Disorder Diagnosis Software Earns FDA Nod

    Biomerics Finishes Expansion of Minnesota Facility

    MPO's Most-Read Stories This Week—Sept. 23

    Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Medtech’s Most Powerful M&A Drivers

    The Link Between Medtech and Connected Medical Devices

    Is the FTC Partly Responsible for Muted M&A Activity?

    Holistic Risk Management: Navigating the Future’s Uncertainties

    Defining End of Life for Medical Devices
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.

    Cirtec Medical

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Providence Enterprise USA Inc.

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.

    Cirtec Medical

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Features

    View from the Top

    A Q&A with Polyzen’s Tilak Shah on his almost 50-year career in materials and medtech.

    Bill Ellerkamp, Contributing Writer07.26.18
    Tilak Shah is an innovator and entrepreneur with almost 50 years’ experience in polymer formulating and processing and product/process development of critical components for the medical device industry. He began his near 50-year career in the medical device industry with Upjohn as a research chemist in 1970. He was involved directly in the formulation, development, and/or commercialization of two of the world’s leading biopolymers—Pellethane 2363 grade and Isoplast—during his tenure at Upjohn, and since then has worked with almost all types of polyurethane biopolymers, including Pellethane, Tecoflex, Tecothane, Carbothane, Tecophilic, Elasthane, Bionate, Carbosil, Biospan, Chronoflex, Elast-Eon, and various other non-urethane biopolymers including Pebax polyamides, Kraton TPEs, various biodegradable polymers, and silicone polymers. He recently retired from Polyzen, a developer and manufacturer of customized polymer-based materials, films, components, and assemblies for the medical device industry, which he founded, and whose roots go back over 30 years.

    Bill Ellerkamp: When you started with Upjohn in 1970, implant grade polymers were very much in their infancy and, while demand was growing, volume consumption was very low. Were you initially focused on developing biopolymers? Which applications were most attractive at that time?
    Tilak Shah:
    I joined Upjohn to develop general thermoplastic polyurethane (TPU) polymers, which was a new product for Upjohn at that time. They were in the process of installing a new pilot line to manufacture TPU polymers, and my job was to review the process and modify or further develop the base polymer into a series of suitable formulations for a variety of applications. At that time, biopolymers per se did not exist. There were some formulations that were emerging, for example, Tecoflex from Thermedics (now part of Lubrizol). Upjohn began to focus in the early 1970s on aromatic polyether polyurethane formulations for biomedical applications. One of the earliest applications I worked on was a polyether formulation that was being solution dipped for components in an artificial heart pump being developed by Dr. Willem Kolff at the University of Utah, the first of which was implanted in 1982 in patient Barney Clark. At the same time, several applications were emerging for extruded catheter tubing for dialysis and pacemaker leads. All these applications evolved from aromatic polyether polyurethane formulations, which I helped develop, and which led to the development of the Pellethane 2363 series of biomedical grade urethanes, with Shore Hardness range from 75A to 75D.

    Ellerkamp: What role did you play in the development and/or commercialization of Pellethane by the medical device industry?
    Shah:
    I played a big role in the development of all types of Pellethane formulations. Shortly after it was launched, I moved into technical service, and moved to Europe in 1975 to set up a TPU plant for Upjohn. I helped transfer, troubleshoot, and scale the facility in the Netherlands. Then I worked with all the users of Pellethane to help them optimize processing conditions on their machinery and equipment. At that time, Upjohn’s TPU customers were primarily injection molding for footwear, seals and gaskets, skateboard wheels, and gears, and extruding for lay flat fire hose and medical tubing, wire, and cable, as well as flat die and blown film applications.

    Ellerkamp: What other early applications were developing in the medical device industry?
    Shah:
    Besides extruded tubing and protective sheathes from PU film, polyurethane low pressure, compliant balloons were an early application that were manufactured by liquid casting of TPU, mainly to replace natural rubber latex and PVC plastisol formulations. The tackiness of TPU initially presented processing challenges, particularly in demolding, for processors accustomed to dipping latex or plastisol. An early adopter in the mid-1980s, in the area of balloons, was a urology company in Germany, which was later acquired by a major U.S. multinational medical device manufacturer. Polyzen is still supplying this customer today with TPU compounded and formulated resins, which were first developed by me.

    Ellerkamp: How did you transition your career from a pure polymer development focus to more of a medical device development and manufacturing focus?
    Shah:
    In 1985, Dow Chemical purchased the Urethane Chemical division of Upjohn, and from 1985 to 1986, I continued my work as the product manager for Upjohn’s new specialty polymers (e.g., Isoplast, Polyamide 7030, Polyimide 2080, and Estamid), and was responsible for developing the Industrial market for those polymers. I was offered a position at Dow’s headquarters in Midland, Mich., or a severance package. My wife and I decided not to go to Midland, and we took the severance package, which became the seed capital to go into business for myself. I started as a consultant, and Dow referred many medical device clients to me for technical service and applications development. I also supported several clients in scale-up and/or startup operations for TPU polymerization plants worldwide. Later in the 1980s, it was becoming clear that the medical device industry offered excellent long-term potential. Balloon catheters were making great inroads into a variety of procedural areas, including angioplasty balloons for cardiovascular applications; thermo-dilution, arterial, and venous balloon catheters for vascular applications; occlusion balloons for urological applications; and rectal balloon catheters for gastrointestinal applications.

    At the same time, latex allergies were emerging as an issue in hospitals. Many people began to explore TPU and silicone dispersions as an alternative to latex-dipped products (i.e., gloves, condoms, catheter balloons). I partnered at that time with others in consulting on the start-up of solution dipping production for glove and condom products. I unfortunately had a bad experience with a partner at the time, which taught me a lot about what not to do, but I was not deterred from my commitment to pursue medical device products and markets. However, gloves and condoms were very high volume and price sensitive applications. At that time, I was continuing with my compounding business, which I had started in 1987, and also began to focus on more specialized applications. Some of these early applications were a polyurethane thin film RF-welded glove, as an alternative to latex gloves to protect doctors’ hands from allergic skin reactions, as well as for semiconductor cleanroom applications; a one-size-fits-all 70 denier Nylon fiber knit glove liner to be worn underneath the latex glove to protect glove touching the skin; and copper-silver coated nylon fiber knit gloves for anti-static electronics applications. Those products were commercialized by my company, Polygenex, and sold under that brand.

    In the early 1990s, I was approached by a leading nitinol medical device development group, which was working with a large medical device OEM on a minimally invasive laparoscopic organ retrieval bag. At the time, I was still a “kitchen and garage” shop. I realized that the project really required a film-welded bag, which the customer fully supported and Polygenex purchased the equipment to RF weld the organ bags. I filed several patents at this time around RF welding TPU thin films (0.001 inch to 0.005 inch film thickness). The customer, in fact, to help accelerate the project, made an investment in and became a shareholder in Polygenex. The product we developed has gone through a number of successive innovations, and subsequent generations, and is still on the market today, available from one of the largest medical device OEMs in the world.

    Ellerkamp: Tell me about the intellectual property you have created in your career?
    Shah:
    I have been named in and/or awarded over 30 patents, going back to 1975 with Upjohn (eight alone at Upjohn). I also received a science award from Upjohn for contributing to basic science and technology. Further, I developed and patented a high-pressure angioplasty balloon out of Isoplast in the late 1980s to replace crosslinked LDPE high pressure balloons for cardiovascular applications. In the early 1990s under Polygenex, I received another nine patents on a variety of processes and/or products, including radiation-resistant film for personal protection devices; glove liners being ambidextrous and universal in size; four patents in dip-molding processes; and three in thin film RF welding processes. And, at Polyzen, we received another 15-plus patents, including five in thermoforming RF welding processes; four on thin multi-layered articulated film welded balloons; two in UV cross linkable balloon formulations; and another five to six in various component processes.

    Ellerkamp: Can you share with me any specific examples of devices that made a significant contribution to the medical device community and healthcare you are particularly proud to have been associated with?
    Shah:
    Of course, the early artificial heart pump, and subsequent LVAD applications. Also, the first laparoscopic organ retrieval bag; a urethane tracheal balloon for a tracheostomy tube; various urethane and silicone coated stents; multi-layered PU film-welded articulated balloons for prostate immobilization; thermoformed RF film-welded balloons for intragastric/obesity treatment, and other applications where high body to neck diameter ratio is desired, as well as many critical components for various gastrointestinal and cardiovascular devices.

    Ellerkamp: You have had extensive experience in a broad cross-section of biopolymers and polymer processing—compounding, dipping, extrusion, blow molding, thermoforming, molding, lamination, welding, etc. How much have these progressed from art to science during your career, and which still have significant elements of art associated with them?
    Shah:
    While many of these processes still remain an art, various companies have worked diligently toward understanding and controlling the variables. Compounding and formulating still remains an art today, as do preparation and drying of all ingredients at their specific conditions and in sequencing the addition of each ingredient. These processes require knowledge, experience, and skills to manage and control the process. Most other melt processes, like extrusion and injection molding of biopolymers, have progressed substantially from art toward science by incorporating better controls and measuring systems, including better drying systems and computerized electronic controllers for temperature and pressure control, automated laser, and ultrasonic thickness gauges for tubing and film extrusion processes. By comparison, extrusion blow molding of specialty urethanes is still relatively an art and very much operator dependent. Liquid processing, especially dip molding and dip coating, remains very much an art, as layer by layer solvent evaporation and variable thickness gradients require more experienced operators, in addition to sophisticated robots. Solid state processes (e.g., secondary processing of films using welding and thermoforming) need various product specific jigs and fixtures to minimize the art and get to a more consistent and repeatable process. With that said, the one key factor to pay attention to with polymer processing is lot to lot variability of PU or Pebax resins. These require an understanding of Melt Flow Index or Intrinsic Viscosity, and knowledge and experience of how material variability interacts with and influences process parameters.

    Ellerkamp: What industry problems, or opportunities, did you found Polyzen to address? How has it evolved?
    Shah:
    Polyzen was initially a hybrid consulting, formulating and compounding, and critical component development company. However, having all three types of processes (melt state, solid state, and liquid state) with a variety of processing equipment under the one roof, Polyzen gradually became a “one-stop-shop” for its customers, including many venture capital-backed companies, as well as development groups of major OEMs. Over time, we started manufacturing more and more of the components for the given devices and eventually getting into full assembly of the device. And for a few customers, we are the end device manufacturer where Polyzen is doing final packaging and supporting outside sterilization services. However, one thing which remains consistent to most of our customer projects is to engage at the identification and selection stage for the polymer and to influence the product and process design of critical components to help optimize overall product functionality, performance, and manufacturability.

    Ellerkamp: How has the medical device industry changed during your career?
    Shah: Over the years, medical devices have become more sophisticated and are requiring more functional and design performance from the properties of biopolymers. Also, integrating electronics into devices has presented new challenges to both materials and processes, as it adds another layer of complexity beyond chemical and mechanical, requiring different knowledge and skill sets of engineering understanding. Also, regulatory constraints are tightening and putting more burden on teams to develop more sophisticated and appropriately designed risk assessments, and verification and validation protocols for components, products, and processes, as well as quality control procedures to ensure every sub-assembly step is in compliance. Lastly, cost is becoming more and more important in the development and manufacturing of devices, requiring companies to think about the value of the device in addition to just addressing the clinical problem.

    Ellerkamp: What is your proudest career achievement?
    Shah:
    Creating Polyzen from a “kitchen and garage” consulting and compounding shop in 1991 into, 27 years later, a full-service innovation driven solutions partner. We are now in 75,000 sq. ft. of manufacturing space with over 110 full-time employees and, looking at the tenure of our employees, with 20 employees over 10 years and four with over 15 years. I feel fortunate to be able to leave behind a legacy and contribution to the development of one of the world’s leading biopolymers in Pellethane 2363, and for having made a difference to the lives of patients around the world.

    Ellerkamp: What’s in store for the future of Polyzen?
    Shah: I am very proud to be working with my two sons, Rubin and Nikin, who bring a set of new energy, skills, and experience to continue to build and grow Polyzen. Rubin has been with me for 15 years, and has an in-depth knowledge and understanding of the medical device industry and our customers. Nikin has rejoined Polyzen for the third time more recently, following his pursuit of a Duke/Fuqua MBA and a stint at Medtronic. I am very confident in my legacy in their hands. I have also hired and am working closely with a well-experienced polymer scientist, Sunil Inamdar, who is challenging me and the organization to move in new and exciting directions.

    Ellerkamp: What is the future development direction you foresee in urethane polymers?
    Shah: There is further progress to be made. I particularly see evolution in bioresorbable, urethane, and full latex replacement materials, with over 1,000 percent elongation and very low set temperatures. In processing technologies, I see evolution in liquid injection molding, reaction injection molding, and micro-molding of urethanes. Also, developing the formulations and process for urethane 3D printing and body part/organ replacement applications. In addition, advancing very rapidly, and offering significant potential, are process and tolerance controls. These challenges will keep me occupied in my “retirement.” 


    Bill Ellerkamp is a medical device industry executive and strategic advisor. He has more than 35-years of operating experience, primarily in medtech contract manufacturing. He currently serves on several boards and, through his consulting group, Acceleration Medtech, provides advisory services to private equity firms, corporations, and independent business owners on strategy, market assessment, business development, operational planning, buy- and sell-side planning, and due diligence. He can be reached at bill.ellerkamp@gmail.com.
    Related Searches
    • market
    • hospitals
    • evolution
    • technology
    Related Knowledge Center
    • Materials
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Molli Surgical Molli Surgical's Breast Tumor Marker
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    RapidPulse Closes $15 Million Series A Financing RapidPulse Closes $15 Million Series A Financing
    Midwest Products & Engineering Acquires MindFlow Design Midwest Products & Engineering Acquires MindFlow Design
    Vicarious Surgical Opens New Corporate Headquarters in Massachusetts Vicarious Surgical Opens New Corporate Headquarters in Massachusetts
    Luis J. Malavé Joins Integrity Applications Board Luis J. Malavé Joins Integrity Applications Board

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21

    • Tubing & Extrusion
      Accu-Tube Appoints Matthew Haddle as CEO

      Accu-Tube Appoints Matthew Haddle as CEO

      Haddle has a track record of leading organizations through strategic expansions across the medical device, aerospace, and industrial sectors.
      Accu-Tube 09.22.21


    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    • CE Mark Granted to Predictive Software for Kidney Allograft Survival

      CE Mark Granted to Predictive Software for Kidney Allograft Survival

      Algorithm gives the probability the graft will still be functional at three, five, and seven years after evaluation by a healthcare professional.
      Cibiltech 09.21.21

    Loading, Please Wait..

    Trending
    • A New Approach To Post-Market Surveillance
    • Diabetes Innovation: MIT Engineers Unveil Implantable Device With Oxygen Factory
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    • Cochlear Implant Study Underway At Mayo Clinic
    • MPO's Most-Read Stories This Week—Sept. 16
    Breaking News
    • Tessy Plastics Names Stafford Frearson as President
    • HoneyNaps' AI Sleep Disorder Diagnosis Software Earns FDA Nod
    • Biomerics Finishes Expansion of Minnesota Facility
    • MPO's Most-Read Stories This Week—Sept. 23
    • Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Releases Sustainability Report for Omega-3s Industry
    ABC’s Journal HerbalGram Celebrates 40th Anniversary
    Curcumin May Be As Effective as PPI for Indigestion
    Coatings World

    Latest Breaking News From Coatings World

    Śnieżka Group Results are Above Expectations in 1H 2023
    ACS Reports Chameleon Inspired Building Coating
    Substrate Wetting Agent Available from BRB International
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 23
    Beckman Coulter Helping Labs Comply With Annex 1 Regulation
    FDA Clears MeMed BV Direct From Whole Blood
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Eftilagimod Cleared for Clinical Trial Use in the UK
    Veranova Names William Sanders Global VP of Chemical Development Ops
    Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    L’Oréal Invests in Chinese Biotech Company ‘Shinehigh Innovation’
    Investindustrial to Acquire 51% Share of Virospack
    Weekly Recap: J&J Updates Visual Identity, L’Oréal Makes Executive Changes & More
    Happi

    Latest Breaking News From Happi

    SC Johnson’s Guardian Spatial Mosquito Repellent Tool Hits Milestone in Field Testing
    Ulta Beauty’s The Joy Project Address Everyone’s Struggle with Negative Self-Talk
    Natural Products Expo East Tradeshow Closes
    Ink World

    Latest Breaking News From Ink World

    Cooper Watson Acquires Tower Products
    The Durst Group Awarded Eight 2023 PRINTING United Alliance Pinnacle Awards
    Weekly Recap: Wikoff Color, HP, INX VC Top This Week’s Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    PRX Market debuts, Tower Products acquired and more
    Flexo Wash to exhibit at FTA Fall Technical Conference
    Recyclable, deinkable stand-up pouch wins Gold in Germany
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: Soft N' Dry Seeks to Expand Private Label Roll Out, Albis Completes Work on Line
    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Completes Work On Extra Wide Carding, Blending Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 23
    Anika Releases RevoMotion Reverse Shoulder Arthroplasty System
    Exactech's Activit-E Polyethylene OK'ed for Vantage Total Ankle
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    HID to Showcase Future-Proof Solutions at GITEX 2023
    Weekly Recap: Mergers and Acquisitions, IEC’s IME Standards Top This Week’s Stories
    EU-Funded Collaboration Hub Aims to Mainstream Printed Electronics

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login